News

Beta cell protection in new-onset type 1 diabetes, sleep and glycaemic control, EASD Global Impact Prize

SURPASS-CVOT primary results, technology in pregnancy, how to run a lab

New clinical guideline on diabetes distress, challenges to precision medicine in type 2 diabetes, ketone monitoring & minimum safety for CGM

Precision medicine approaches for monogenic diabetes, CGM in India and in exercise, and the emerging consensus on T1D screening

Early-onset and difficult-to-manage type 2 diabetes, and a new approach to preserve muscle when losing weight

Cardiovascular benefits of oral GLP-1RA, stagnation in HbA1c target achievement, and a paradigm shift in basal insulin therapy

Assessment of hypos revisited, microbes in type 1 diabetes pathogenesis, and a new class of GLP-1 RA

Hot debates on innovations, high-stakes treatment choices, and CGM as OTC 

Cure for type 1 diabetes and key results of the dt-report.

Time in tight range, vision for AID, and obesity management.

Key innovations, screening, and fully-closed loop approaches.

The final day of the 84th ADA Scientific Sessions has arrived. In our final Newsflash episode, Alice Cheng reviews major advances and discoveries in diabetes in the year gone by.

Incretin-based therapies are our focus in the Day 3 Newsflash from the 84th ADA Scientific Sessions. Ildiko Lingvay discusses their role in preventing the progression from prediabetes to diabetes. Michael Na...

A priority to focus on in people with newly diagnosed type 2 diabetes is remission, says Roy Taylor in the Newsflash from Day 2 of the ADA Scientific Sessions, emphasising the current international consensus.

The EASD e-Learning Newsflash is back, bringing you highlights from the 84th ADA Scientific Session.

Challenges for people with t1d doing sports and access to diabetes tech in lower income countries were some of the focus topics on the final day of ATTD2024. Julia Mader sums up her impressions from the conf...

We focus on Chantal Mathieu’s update on CGM derived data in weekly insulins in our newsflash from #ATTD2024 Day 3. Another standout moment for us was the EUDF joint session. It explored how artificial ...

Day 2 of ATTD 2024 came with updates on hypoglycaemia with Prof Pratik Choudhary and the unveiling of new monitoring guidance for presymptomatic type 1 diabetes with Co-Ch...

Highlights from Day1 of the 17th Conference on Advanced Technologies and Treatments for Diabetes with Prof Melanie Davies and Renza Scibilia.